US Stock MarketDetailed Quotes

WENAW ANEW MEDICAL INC C/WTS 21/06/2029 (TO PUR COM)

Watchlist
  • 0.040
  • 0.0000.00%
Close Sep 16 16:00 ET
0Market Cap0.00P/E (TTM)

ANEW MEDICAL INC C/WTS 21/06/2029 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-21.98K
-111.10%-599.57K
-284.02K
Net income from continuing operations
---672.04K
46.03%-598.59K
---1.11M
Change In working capital
--362.82K
-161.75%-2.38K
--3.85K
-Change in prepaid assets
--3.84K
--0
--1.62K
-Change in payables and accrued expense
--358.98K
-206.30%-2.38K
--2.24K
Cash from discontinued investing activities
Operating cash flow
---21.98K
-111.10%-599.57K
---284.02K
Investing cash flow
Cash flow from continuing investing activities
-123.5K
-125.41K
0
Net intangibles purchase and sale
---123.5K
---125.41K
--0
Cash from discontinued investing activities
Investing cash flow
---123.5K
---125.41K
--0
Financing cash flow
Cash flow from continuing financing activities
175K
100.00%500K
250K
Net common stock issuance
--50K
200.00%750K
--250K
Net preferred stock issuance
--125K
----
----
Net other financing activities
----
---250K
----
Cash from discontinued financing activities
Financing cash flow
--175K
100.00%500K
--250K
Net cash flow
Beginning cash position
--2.81K
-10.16%300.85K
--334.87K
Current changes in cash
--29.53K
-561.30%-224.98K
---34.02K
End cash Position
--32.34K
-74.78%75.87K
--300.85K
Free cash flow
---145.47K
-155.26%-724.98K
---284.02K
Currency Unit
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(Q1)Mar 31, 2024(FY)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -21.98K-111.10%-599.57K-284.02K
Net income from continuing operations ---672.04K46.03%-598.59K---1.11M
Change In working capital --362.82K-161.75%-2.38K--3.85K
-Change in prepaid assets --3.84K--0--1.62K
-Change in payables and accrued expense --358.98K-206.30%-2.38K--2.24K
Cash from discontinued investing activities
Operating cash flow ---21.98K-111.10%-599.57K---284.02K
Investing cash flow
Cash flow from continuing investing activities -123.5K-125.41K0
Net intangibles purchase and sale ---123.5K---125.41K--0
Cash from discontinued investing activities
Investing cash flow ---123.5K---125.41K--0
Financing cash flow
Cash flow from continuing financing activities 175K100.00%500K250K
Net common stock issuance --50K200.00%750K--250K
Net preferred stock issuance --125K--------
Net other financing activities -------250K----
Cash from discontinued financing activities
Financing cash flow --175K100.00%500K--250K
Net cash flow
Beginning cash position --2.81K-10.16%300.85K--334.87K
Current changes in cash --29.53K-561.30%-224.98K---34.02K
End cash Position --32.34K-74.78%75.87K--300.85K
Free cash flow ---145.47K-155.26%-724.98K---284.02K
Currency Unit USDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data